{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:16:15Z","timestamp":1793042175829,"version":"4.5.0"},"reference-count":171,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Gastric cancer ranks among the most prevalent malignant tumors globally, with its immunotherapeutic efficacy constrained by the intricate tumor microenvironment (TME). This review provides a systematic elucidation of the dynamic interaction axis of \u201cnutrient competition-metabolic crosstalk-immunosuppression\u201d within the TME of gastric cancer, approached from a network perspective. Initially, the hypoxic, acidic, and nutrient-deficient conditions of the TME establish a metabolic pressure foundation, compelling cancer and immune cells to engage in intense competition for essential nutrients, thereby inducing a state of metabolic deprivation in effector T cells. Subsequently, this competitive dynamic results in the accumulation of immunosuppressive metabolites, including lactic acid, adenosine, kynurenine, and prostaglandin E2. These metabolites, rather than being mere waste products, form a complex metabolic crosstalk network that actively suppresses effective immune function and reshapes the immunosuppressive niche through mechanisms such as receptor signaling and epigenetic modification. Ultimately, this multi-layered metabolic reprogramming network collectively facilitates immune evasion and resistance to immunotherapy in gastric cancer. A comprehensive analysis of the network is anticipated to furnish a vital theoretical foundation for the development of novel therapeutic strategies. These strategies may include targeting pivotal metabolic nodes, alleviating immunosuppression, and integrating immune checkpoint blockade, all of which are expected to enhance the clinical prognosis of patients with gastric cancer.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1801318","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:19Z","timestamp":1783575259000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic reprogramming networks in the gastric cancer tumor microenvironment: an integrated axis of nutrient competition, metabolic crosstalk, and immunosuppression"],"prefix":"10.3389","volume":"17","author":[{"given":"Xiaona","family":"He","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Tumor Surgery, The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Second Hospital & Clinical Medical School, Lanzhou University","place":["Lanzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet (London England)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41419-025-07385-7","article-title":"Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies","volume":"16","author":"Luo","year":"2025","journal-title":"Cell Death Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.064","article-title":"Nutrient competition: A new axis of tumor immunosuppression","volume":"162","author":"Sukumar","year":"2015","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12123802","article-title":"Characteristics of the tumor microenvironment that influence immune cell functions: Hypoxia, oxidative stress, metabolic alterations","volume":"12","author":"Augustin","year":"2020","journal-title":"Cancers"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113244","article-title":"Lactate in the tumor microenvironment: An essential molecule in cancer progression and treatment","volume":"12","author":"P\u00e9rez-Tom\u00e1s","year":"2020","journal-title":"Cancers"},{"key":"B8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2016.04.001","article-title":"Immunosuppressive activities of adenosine in cancer","volume":"29","author":"Allard","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101891","article-title":"Immune cell - produced ROS and their impact on tumor growth and metastasis","volume":"42","author":"Kennel","year":"2021","journal-title":"Redox Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/cells14141096","article-title":"The role of lactate in immune regulation: A metabolic rheostat via transporters, receptors, and epigenetic modifiers","volume":"14","author":"Choi","year":"2025","journal-title":"Cells"},{"key":"B11","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s40425-019-0719-5","article-title":"Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8(+) T cells","volume":"7","author":"Mastelic-Gavillet","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652687","article-title":"Metabolic reprogramming and reactive oxygen species in T cell immunity","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1082057","article-title":"The hypoxia-inducible factor-1\u03b1 in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting","volume":"11","author":"Ozcan","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.279","article-title":"Hypoxia-induced FOXO4\/LDHA axis modulates gastric cancer cell glycolysis and progression","volume":"11","author":"Wang","year":"2021","journal-title":"Clin Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12935-024-03520-0","article-title":"Acid affairs in anti-tumour immunity","volume":"24","author":"Cappellesso","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103627","article-title":"Lactate in the tumour microenvironment: From immune modulation to therapy","volume":"73","author":"Wang","year":"2021","journal-title":"EBioMedicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.932055","article-title":"Lactate from the tumor microenvironment - A key obstacle in NK cell-based immunotherapies","volume":"13","author":"Jedli\u010dka","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi4191","article-title":"A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression","volume":"9","author":"Plebanek","year":"2024","journal-title":"Sci Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2024.2320951","article-title":"Lactate\/GPR81 recruits regulatory T cells by modulating CX3CL1 to promote immune resistance in a highly glycolytic gastric cancer","volume":"13","author":"Su","year":"2024","journal-title":"Oncoimmunology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202501238","article-title":"NDRG1-driven lactate accumulation promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment","volume":"12","author":"Wu","year":"2025","journal-title":"Advanced Sci (Weinheim Baden-Wurttemberg Germany)"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00109","article-title":"A metabolic immune checkpoint: Adenosine in tumor microenvironment","volume":"7","author":"Ohta","year":"2016","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.04.008","article-title":"Extracellular ATP and adenosine in cancer pathogenesis and treatment","volume":"7","author":"Chiarella","year":"2021","journal-title":"Trends Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00162","article-title":"Adenosine A2A receptor stimulation inhibits TCR-induced Notch1 activation in CD8+T-cells","volume":"10","author":"Sorrentino","year":"2019","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-006728","article-title":"Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2\/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes","volume":"11","author":"Solvay","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4137\/ijtr.S38355","article-title":"The kynurenine pathway is a double-edged sword in immune-privileged sites and in cancer: Implications for immunotherapy","volume":"9","author":"Routy","year":"2016","journal-title":"Int J Tryptophan Res IJTR"},{"key":"B26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12943-024-02164-y","article-title":"Molecular mechanisms and therapeutic significance of tryptophan metabolism and signaling in cancer","volume":"23","author":"Yan","year":"2024","journal-title":"Mol Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000004205","article-title":"Activation of the aryl hydrocarbon receptor ameliorates acute rejection of rat liver transplantation by regulating Treg proliferation and PD-1 expression","volume":"106","author":"Cao","year":"2022","journal-title":"Transplantation"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.32010","article-title":"Cyclooxygenase-2 in gastrointestinal Malignancies","volume":"125","author":"Nagaraju","year":"2019","journal-title":"Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiaf034","article-title":"Distinct roles of PGE2 signaling via EP2 and EP4 in circulating pDCs: Implications for immune modulation in the tumor microenvironment","volume":"117","author":"Cuenca-Escalona","year":"2025","journal-title":"J Leukocyte Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1355769","article-title":"EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells","volume":"15","author":"Cuenca-Escalona","year":"2024","journal-title":"Front Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.Capr-21-0572","article-title":"The COX-2-PGE2 pathway promotes tumor evasion in colorectal adenomas","volume":"15","author":"Wei","year":"2022","journal-title":"Cancer Prev Res (Philadelphia Pa)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00938","article-title":"Myeloid cell-derived arginase in cancer immune response","volume":"11","author":"Grzywa","year":"2020","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.immuni.2025.07.007","article-title":"Polyamines regulate adaptive antitumor immunity by functional specialization of regulatory T cells","volume":"58","author":"B\u00fcndgen","year":"2025","journal-title":"Immunity"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116030","article-title":"Effect of metabolic reprogramming on the immune microenvironment in gastric cancer","volume":"170","author":"Shang","year":"2024","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3892\/or.2024.8847","article-title":"Role and value of the tumor microenvironment in the progression and treatment resistance of gastric cancer (review)","volume":"53","author":"Yun","year":"2025","journal-title":"Oncol Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2024.03.008","article-title":"Gastric cancer immunosuppressive microenvironment heterogeneity: Implications for therapy development","volume":"10","author":"Yasuda","year":"2024","journal-title":"Trends Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1639823","article-title":"The impact of aberrant lipid metabolism on the immune microenvironment of gastric cancer: A mini review","volume":"16","author":"Chen","year":"2025","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1358511","article-title":"The viral etiology of EBV-associated gastric cancers contributes to their unique pathology, clinical outcomes, treatment responses and immune landscape","volume":"15","author":"Salnikov","year":"2024","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112433","article-title":"Tumor microenvironment characteristics of lipid metabolism reprogramming related to ferroptosis and EndMT influencing prognosis in gastric cancer","volume":"137","author":"Zhao","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1186\/s12885-024-12861-y","article-title":"Revealing the crosstalk between LOX(+) fibroblast and M2 macrophage in gastric cancer by single-cell sequencing","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1591123","article-title":"Integrative single-cell and spatial transcriptomics uncover ELK4-mediated mechanisms in NDUFAB1+ tumor cells driving gastric cancer progression, metabolic reprogramming, and immune evasion","volume":"16","author":"Sun","year":"2025","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/cells11152373","article-title":"Single cell analysis reveals reciprocal tumor-macrophage intercellular communications related with metabolic reprogramming in stem-like gastric cancer","volume":"11","author":"Sung","year":"2022","journal-title":"Cells"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s10528-024-10922-2","article-title":"Single-cell RNA sequencing demonstrates the heterogeneity of different molecular subtypes in gastric cancer","volume":"63","author":"Ren","year":"2025","journal-title":"Biochem Genet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1355269","article-title":"Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay","volume":"15","author":"Lin","year":"2024","journal-title":"Front Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"8787","DOI":"10.1038\/s41598-023-35395-y","article-title":"Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in gastric cancer","volume":"13","author":"Tao","year":"2023","journal-title":"Sci Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221839","article-title":"Nutrients: Signal 4 in T cell immunity","volume":"221","author":"Raynor","year":"2024","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.115206","article-title":"Tumor-induced metabolic immunosuppression: Mechanisms and therapeutic targets","volume":"44","author":"Ricci","year":"2025","journal-title":"Cell Rep"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116463","article-title":"Metabolic regulation of immunity in the tumor microenvironment","volume":"44","author":"Li","year":"2025","journal-title":"Cell Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2023.06.003","article-title":"Beggars banquet: Metabolism in the tumor immune microenvironment and cancer therapy","volume":"35","author":"Zou","year":"2023","journal-title":"Cell Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2023.08.011","article-title":"Tumor microenvironmental nutrients, cellular responses, and cancer","volume":"30","author":"Lobel","year":"2023","journal-title":"Cell Chem Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.cmet.2023.07.001","article-title":"Tumor aerobic glycolysis confers immune evasion through modulating sensitivity to T cell-mediated bystander killing via TNF-\u03b1","volume":"35","author":"Wu","year":"2023","journal-title":"Cell Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"The tumor microenvironment represses T cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41419-022-04821-w","article-title":"Impacts and mechanisms of metabolic reprogramming of tumor microenvironment for immunotherapy in gastric cancer","volume":"13","author":"Zhao","year":"2022","journal-title":"Cell Death Dis"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-03045-2","article-title":"Metabolic support of tumour-infiltrating regulatory T cells by lactic acid","volume":"591","author":"Watson","year":"2021","journal-title":"Nature"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115369","article-title":"Immunometabolic attributes and mitochondria-associated signaling of tumor-associated macrophages in tumor microenvironment modulate cancer progression","volume":"208","author":"Dubey","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-19-2994","article-title":"Enhanced lipid accumulation and metabolism are required for the differentiation and activation of tumor-associated macrophages","volume":"80","author":"Su","year":"2020","journal-title":"Cancer Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12967-025-06279-8","article-title":"MCT4: a key player influencing gastric cancer metastasis and participating in the regulation of the metastatic immune microenvironment","volume":"23","author":"Jiang","year":"2025","journal-title":"J Transl Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12964-022-00909-0","article-title":"Reprogramming of glutamine metabolism and its impact on immune response in the tumor microenvironment","volume":"20","author":"Ma","year":"2022","journal-title":"Cell Communication Signaling CCS"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3796","article-title":"\u03b1-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming","volume":"18","author":"Liu","year":"2017","journal-title":"Nat Immunol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110660","article-title":"SENP1-Sirt3 signaling promotes \u03b1-ketoglutarate production during M2 macrophage polarization","volume":"39","author":"Zhou","year":"2022","journal-title":"Cell Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1172\/jci131859","article-title":"Targeting glutamine metabolism enhances tumor-specific immunity by modulating suppressive myeloid cells","volume":"130","author":"Oh","year":"2020","journal-title":"J Clin Invest"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00168","article-title":"The sweet surrender: How myeloid cell metabolic plasticity shapes the tumor microenvironment","volume":"6","author":"Sieow","year":"2018","journal-title":"Front Cell Dev Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155655","article-title":"IDO1-mediated catabolism of tryptophan in gastric tumors: Its potential role in the axis of histopathology, differentiation and metastasis","volume":"263","author":"Horozoglu","year":"2024","journal-title":"Pathol Res Pract"},{"key":"B65","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","article-title":"Amino acid metabolism in tumor biology and therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-023-01456-4","article-title":"Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer","volume":"27","author":"Tsutsumi","year":"2024","journal-title":"Gastric Cancer Off J Int Gastric Cancer Assoc Japanese Gastric Cancer Assoc"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-025-03960-8","article-title":"Myeloid-derived suppressor cells modulation in the context of tumor microenvironment for gastric cancer","volume":"27","author":"Portillo-Mi\u00f1o","year":"2025","journal-title":"Clin Trans Oncol Off Publ Fed Spanish Oncol Societies Natl Cancer Institute Mexico"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-19-0702","article-title":"Fatty acid oxidation controls CD8(+) tissue-resident memory T-cell survival in gastric adenocarcinoma","volume":"8","author":"Lin","year":"2020","journal-title":"Cancer Immunol Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12944-023-01807-1","article-title":"Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy","volume":"22","author":"Qiao","year":"2023","journal-title":"Lipids Health Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004584","article-title":"Lipid-loaded macrophages as new therapeutic target in cancer","volume":"10","author":"Marelli","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8(+) T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202451102","article-title":"Metabolic dialogue shapes immune response in the tumor microenvironment","volume":"55","author":"Gao","year":"2025","journal-title":"Eur J Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1038\/s41467-019-10015-4","article-title":"Competition for nutrients and its role in controlling immune responses","volume":"10","author":"Kedia-Mehta","year":"2019","journal-title":"Nat Commun"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1554028","article-title":"Iron and energy metabolic interactions in Treg-mediated immune regulation","volume":"16","author":"Savagner","year":"2025","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s40164-025-00719-3","article-title":"Lactate and lactylation in cancer: drivers of immune suppression and microenvironmental reprogramming","volume":"14","author":"Ji","year":"2025","journal-title":"Exp Hematol Oncol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01143","article-title":"Lactate in the regulation of tumor microenvironment and therapeutic approaches","volume":"9","author":"de la Cruz-L\u00f3pez","year":"2019","journal-title":"Front Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11684-025-1148-0","article-title":"Lactate and lactylation in tumor immunity","volume":"19","author":"Song","year":"2025","journal-title":"Front Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189339","article-title":"Research progress on the regulatory role of lactate and lactylation in tumor microenvironment","volume":"1880","author":"Gao","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1124\/pharmrev.121.000528","article-title":"ATP and adenosine metabolism in cancer: Exploitation for therapeutic gain","volume":"74","author":"Yegutkin","year":"2022","journal-title":"Pharmacol Rev"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.25873","article-title":"Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer","volume":"233","author":"Kazemi","year":"2018","journal-title":"J Cell Physiol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914928","article-title":"The immune regulatory role of adenosine in the tumor microenvironment","volume":"24","author":"Xing","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.Cir-22-0113","article-title":"Adenosine A2a receptor antagonism restores additive cytotoxicity by cytotoxic T cells in metabolically perturbed tumors","volume":"10","author":"Slaats","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118188","article-title":"Co-targeting the CD73-adenosinergic axis enhances the anti-tumor efficacy of anti-PD-L1 immunotherapy in bladder cancer","volume":"188","author":"Furriel","year":"2025","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B84","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"B85","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s40425-017-0308-4","article-title":"Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment","volume":"5","author":"Steggerda","year":"2017","journal-title":"J Immunother Cancer"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e318247a5e9","article-title":"Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4","volume":"35","author":"Holt","year":"2012","journal-title":"J Immunotherapy (Hagerstown Md 1997)"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1099811","article-title":"Cyclooxygenase-2-prostaglandin E2 pathway: A key player in tumor-associated immune cells","volume":"13","author":"Jin","year":"2023","journal-title":"Front Oncol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1524651","article-title":"Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells","volume":"14","author":"Kang","year":"2024","journal-title":"Front Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41420-024-02011-5","article-title":"AMPK-a key factor in crosstalk between tumor cell energy metabolism and immune microenvironment","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4062\/biomolther.2023.222","article-title":"AMPK alchemy: Therapeutic potentials in allergy, aging, and cancer","volume":"32","author":"Pokhrel","year":"2024","journal-title":"Biomolecules Ther"},{"key":"B91","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-026-02582-0","article-title":"Metabolic reprogramming in cancer: signaling pathways and therapeutic targets","volume":"25","author":"Dong","year":"2026","journal-title":"Mol Cancer"},{"key":"B92","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-026-00427-2","article-title":"Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities","volume":"7","author":"Yu","year":"2026","journal-title":"Mol BioMed"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000040273","article-title":"Central role of hypoxia-inducible factor-1\u03b1 in metabolic reprogramming of cancer cells: A review","volume":"103","author":"Zhu","year":"2024","journal-title":"Medicine"},{"key":"B94","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3892\/ol.2025.15339","article-title":"Advancements in research on the role of the key glycolytic enzyme hexokinase 2 in the regulation of tumor immune evasion (review)","volume":"30","author":"Qian","year":"2025","journal-title":"Oncol Lett"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.31557\/apjcp.2024.25.4.1121","article-title":"Regulation of hypoxia dependent reprogramming of cancer metabolism: Role of HIF-1 and its potential therapeutic implications in leukemia","volume":"25","author":"Pandey","year":"2024","journal-title":"Asian Pacific J Cancer Prev APJCP"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgx034","article-title":"Enhanced glycolysis, regulated by HIF-1\u03b1 via MCT-4, promotes inflammation in arsenite-induced carcinogenesis","volume":"38","author":"Luo","year":"2017","journal-title":"Carcinogenesis"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J Biol Chem"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.32604\/or.2025.065953","article-title":"Hypoxic link between cancer cells and the immune system: The role of adenosine and lactate","volume":"33","author":"Alvarado-Ortiz","year":"2025","journal-title":"Oncol Res"},{"key":"B99","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1007\/s12672-025-04001-0","article-title":"Cancer immunotherapy by adenosinergic CD39 and CD73 as emerging immune checkpoints","volume":"16","author":"Yin","year":"2025","journal-title":"Discover Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2023-0871","article-title":"Regulatory role of CD39 and CD73 in tumor immunity","volume":"20","author":"Kaplinsky","year":"2024","journal-title":"Future Oncol (London England)"},{"key":"B101","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12943-025-02460-1","article-title":"Immunometabolism: crosstalk with tumor metabolism and implications for cancer immunotherapy","volume":"24","author":"Zhang","year":"2025","journal-title":"Mol Cancer"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.7150\/thno.53749","article-title":"Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1595162","article-title":"Research progress on the interaction between glucose metabolic reprogramming and lactylation in tumors","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1690068","article-title":"Lactylation and antitumor immunity","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102700","article-title":"A complex metabolic network confers immunosuppressive functions to myeloid-derived suppressor cells (MDSCs) within the tumour microenvironment","volume":"10","author":"Hofer","year":"2021","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03581-0","article-title":"Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance","volume":"78","author":"Wei","year":"2021","journal-title":"Cell Mol Life Sci CMLS"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2174\/0113892010415740251006000648","article-title":"Lactate as a metabolic regulator in the tumor microenvironment: Linking immunosuppression to epigenetic reprogramming","author":"Cheng","year":"2025","journal-title":"Curr Pharm Biotechnol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/cad.0000000000000684","article-title":"Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells","volume":"30","author":"He","year":"2019","journal-title":"Anti-Cancer Drugs"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.6155","article-title":"Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway","volume":"39","author":"Wu","year":"2018","journal-title":"Oncol Rep"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105406","article-title":"Targeting lactate dehydrogenase A with catechin resensitizes SNU620\/5FU gastric cancer cells to 5-fluorouracil","volume":"22","author":"Han","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B111","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1016\/j.celrep.2018.11.043","article-title":"Dual inhibition of the lactate transporters MCT1 and MCT4 is synthetic lethal with metformin due to NAD+ depletion in cancer cells","volume":"25","author":"Benjamin","year":"2018","journal-title":"Cell Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033418","article-title":"Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis","volume":"7","author":"Sonveaux","year":"2012","journal-title":"PloS One"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-18-0668","article-title":"IDO1 and kynurenine pathway metabolites activate PI3K-Akt signaling in the neoplastic colon epithelium to promote cancer cell proliferation and inhibit apoptosis","volume":"79","author":"Bishnupuri","year":"2019","journal-title":"Cancer Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"18741","DOI":"10.1038\/s41598-025-03446-1","article-title":"Metabolomic reprogramming of the tumor microenvironment by dual arginase inhibitor OATD-02 boosts anticancer immunity","volume":"15","author":"Grzybowski","year":"2025","journal-title":"Sci Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-018-2605-9","article-title":"Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth","volume":"144","author":"Ye","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1177\/15347354211045349","article-title":"Inhibition of glutamine uptake improves the efficacy of cetuximab on gastric cancer","volume":"20","author":"Ma","year":"2021","journal-title":"Integr Cancer Therapies"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.01.012","article-title":"Targeting apoptosis pathways by celecoxib in cancer","volume":"332","author":"Jendrossek","year":"2013","journal-title":"Cancer Lett"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110389","article-title":"Combined chemotherapy with cyclooxygenase-2 (COX-2) inhibitors in treating human cancers: Recent advancement","volume":"129","author":"Li","year":"2020","journal-title":"Biomedicine Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-21-0802","article-title":"Targeting CD73 with AB680 (Quemliclustat), a novel and potent small-molecule CD73 inhibitor, restores immune functionality and facilitates antitumor immunity","volume":"21","author":"Piovesan","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01044","article-title":"Targeting metabolism of extracellular nucleotides via inhibition of ectonucleotidases CD73 and CD39","volume":"63","author":"Jeffrey","year":"2020","journal-title":"J Med Chem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.Mct-23-0865","article-title":"Characterization of AB598, a CD39 enzymatic inhibitory antibody for the treatment of solid tumors","volume":"23","author":"Anderson","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2025_250321N133","article-title":"High glycolysis phenotype influences Malignant progression and poor prognosis of gastric cancer through the PI3K\/AKT pathway","volume":"72","author":"Liu","year":"2025","journal-title":"Neoplasma"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v16.i7.3097","article-title":"Glycolysis-related five-gene signature correlates with prognosis and immune infiltration in gastric cancer","volume":"16","author":"Meng","year":"2024","journal-title":"World J Gastrointestinal Oncol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12013-022-01112-1","article-title":"Protein phosphatase 2a inhibits gastric cancer cell glycolysis by reducing MYC signaling","volume":"81","author":"Cai","year":"2023","journal-title":"Cell Biochem Biophys"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2018.1511706","article-title":"Lactate transporters as therapeutic targets in cancer and inflammatory diseases","volume":"22","author":"Pucino","year":"2018","journal-title":"Expert Opin Ther Targets"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2018.12.011","article-title":"Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer","volume":"57","author":"Wang","year":"2019","journal-title":"Phytomedicine Int J Phytotherapy Phytopharmacology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010049","article-title":"Metformin impairs glutamine metabolism and autophagy in tumour cells","volume":"8","author":"Saladini","year":"2019","journal-title":"Cells"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-025-02305-0","article-title":"Inhibition of integrin \u03b13 suppresses gastric cancer progression via STAT3-mediated regulation of SLC1A5-dependent glutamine uptake","volume":"60","author":"Zhu","year":"2025","journal-title":"J Gastroenterol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14712","article-title":"Mitochondrial glutamine metabolism determines senescence induction after chemotherapy","volume":"40","author":"Kim","year":"2020","journal-title":"Anticancer Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies","volume":"2","author":"Fu","year":"2021","journal-title":"MedComm"},{"key":"B131","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12967-024-05055-4","article-title":"PLA2G4A and ACHE modulate lipid profiles via glycerophospholipid metabolism in platinum-resistant gastric cancer","volume":"22","author":"Chen","year":"2024","journal-title":"J Transl Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216305","article-title":"HKDC1 reprograms lipid metabolism to enhance gastric cancer metastasis and cisplatin resistance via forming a ribonucleoprotein complex","volume":"569","author":"Zhao","year":"2023","journal-title":"Cancer Lett"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v16.i6.2781","article-title":"Ferroptosis regulating lipid peroxidation metabolism in the occurrence and development of gastric cancer","volume":"16","author":"Wang","year":"2024","journal-title":"World J Gastrointestinal Oncol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7735","article-title":"Targeting lipid metabolism with natural products: A novel strategy for gastrointestinal cancer therapy","volume":"37","author":"Guo","year":"2023","journal-title":"Phytotherapy Res PTR"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.07.021","article-title":"Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy","volume":"14","author":"Zhang","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B136","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.intimp.2018.07.023","article-title":"Adenosine signaling: Next checkpoint for gastric cancer immunotherapy","volume":"63","author":"Shi","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123837","article-title":"Targeting adenosine receptor signaling in cancer immunotherapy","volume":"19","author":"Sek","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.06.020","article-title":"Preventing ATP degradation by ASO-mediated knockdown of CD39 and CD73 results in A2aR-independent rescue of T cell proliferation","volume":"21","author":"Festag","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.Cd-19-0541","article-title":"Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity","volume":"9","author":"Li","year":"2019","journal-title":"Cancer Discov"},{"key":"B140","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1016\/j.celrep.2019.04.091","article-title":"Blocking antibodies targeting the CD39\/CD73 immunosuppressive pathway unleash immune responses in combination cancer therapies","volume":"27","author":"Perrot","year":"2019","journal-title":"Cell Rep"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0376-4","article-title":"Targeting CD39 in cancer","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3744","article-title":"Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (review)","volume":"42","author":"Sun","year":"2018","journal-title":"Int J Mol Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00819","article-title":"Eicosanoids in cancer: Prostaglandin E(2) receptor 4 in cancer therapeutics and immunotherapy","volume":"11","author":"Ching","year":"2020","journal-title":"Front Pharmacol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.immuni.2020.10.020","article-title":"Antagonistic inflammatory phenotypes dictate tumor fate and response to immune checkpoint blockade","volume":"53","author":"Bonavita","year":"2020","journal-title":"Immunity"},{"key":"B145","doi-asserted-by":"publisher","first-page":"9464","DOI":"10.1038\/s41467-024-53706-3","article-title":"Prostaglandin E(2)-EP2\/EP4 signaling induces immunosuppression in human cancer by impairing bioenergetics and ribosome biogenesis in immune cells","volume":"15","author":"Punyawatthananukool","year":"2024","journal-title":"Nat Commun"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114855","article-title":"Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity","volume":"43","author":"Pedde","year":"2024","journal-title":"Cell Rep"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1158\/2767-9764.Crc-23-0249","article-title":"Dual blockade of EP2 and EP4 signaling is required for optimal immune activation and antitumor activity against prostaglandin-expressing tumors","volume":"3","author":"Francica","year":"2023","journal-title":"Cancer Res Commun"},{"key":"B148","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1124\/pharmrev.123.000901","article-title":"Prostaglandin E2 in the tumor microenvironment, a convoluted affair mediated by EP receptors 2 and 4","volume":"76","author":"Santiso","year":"2024","journal-title":"Pharmacol Rev"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.759015","article-title":"Metabolic reprogramming in the tumor microenvironment with immunocytes and immune checkpoints","volume":"11","author":"Xu","year":"2021","journal-title":"Front Oncol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.697894","article-title":"Targeted glucose or glutamine metabolic therapy combined with PD-1\/PD-L1 checkpoint blockade immunotherapy for the treatment of tumors - mechanisms and strategies","volume":"11","author":"Ma","year":"2021","journal-title":"Front Oncol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.745209","article-title":"Metabolic reprogramming in gastric cancer: Trojan horse effect","volume":"11","author":"Bin","year":"2021","journal-title":"Front Oncol"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115630","article-title":"Glucose metabolism reprogramming in gastric cancer: Implications for tumor","volume":"167","author":"Li","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-025-01675-x","article-title":"Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer","volume":"29","author":"Cao","year":"2025","journal-title":"Gastric Cancer: Off J Int Gastric Cancer Assoc Japanese Gastric Cancer Assoc"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1508730","article-title":"Targeting amino acid metabolism to inhibit gastric cancer progression and promote anti-tumor immunity: a review","volume":"16","author":"Jiang","year":"2025","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.801959","article-title":"A novel lactate metabolism-related gene signature for predicting clinical outcome and tumor microenvironment in hepatocellular carcinoma","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1485580","article-title":"Lactylation-related gene signature accurately predicts prognosis and immunotherapy response in gastric cancer","volume":"14","author":"Sun","year":"2024","journal-title":"Front Oncol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1007\/s12672-025-02782-y","article-title":"Lactate metabolism-related genes serve as potential biomarkers for predicting gastric cancer progression and immunotherapy","volume":"16","author":"Yuan","year":"2025","journal-title":"Discover Oncol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.2174\/0115665240290237240424054233","article-title":"Establishment and validation of lactate metabolism-related genes as a prognostic model for gastric cancer","volume":"25","author":"Hu","year":"2025","journal-title":"Curr Mol Med"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/pai.0000000000001238","article-title":"IDO1 expression and CD8+ T-cell levels are useful prognostic biomarkers in preoperative gastric cancer specimens before neoadjuvant chemotherapy","volume":"33","author":"Chen","year":"2025","journal-title":"Appl Immunohistochemistry Mol Morphology: AIMM"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1466779","article-title":"Integrated analyses reveal IDO1 as a prognostic biomarker coexpressed with PD-1 on tumor-associated macrophages in esophageal squamous cell carcinoma","volume":"15","author":"Peng","year":"2024","journal-title":"Front Pharmacol"},{"key":"B161","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13046-019-1318-5","article-title":"A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis","volume":"38","author":"Xiang","year":"2019","journal-title":"J Exp Clin Cancer Research: CR"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2024.01.043","article-title":"Immune landscape of Epstein-Barr virus-associated gastric cancer: Analysis from a Western academic institution","volume":"296","author":"Yee","year":"2024","journal-title":"J Surg Res"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155743","article-title":"Immune biomarkers and predictive signatures in gastric cancer: Optimizing immunotherapy responses","volume":"265","author":"Vickram","year":"2025","journal-title":"Pathol Res Pract"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05319-7","article-title":"TAP1 promotes immune escape by activating JNK\/STAT1\/PD-L1 signaling in EBV-associated gastric cancer","volume":"480","author":"Shan","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-025-01626-6","article-title":"Dihydrotestosterone-androgen receptor signaling suppresses EBV-positive gastric cancer through DNA demethylation-mediated viral reactivation","volume":"28","author":"Cho","year":"2025","journal-title":"Gastric Cancer: Off J Int Gastric Cancer Assoc Japanese Gastric Cancer Assoc"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-025-01618-6","article-title":"Predictive value of EBV-positivity in patients with gastric cancer treated with first-line nivolumab plus chemotherapy","volume":"28","author":"Kim","year":"2025","journal-title":"Gastric Cancer: Off J Int Gastric Cancer Assoc Japanese Gastric Cancer Assoc"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-023-03506-9","article-title":"An exploration of gastric cancer with heterogeneous mismatch repair status","volume":"482","author":"Wang","year":"2023","journal-title":"Virchows Archiv: Int J Pathol"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112296","article-title":"Metabolic alterations and immune heterogeneity in gastric cancer metastasis","volume":"28","author":"Zeng","year":"2025","journal-title":"iScience"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1734244","article-title":"Modeling the pre-metastatic niche of gastric cancer peritoneal metastasis under spatiotemporal resolution and investigating EVs-mediated immune suppression","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1097\/js9.0000000000003944","article-title":"Intraperitoneal metastasis of gastric cancer: New insights on resident macrophages","volume":"112","author":"Yu","year":"2026","journal-title":"Int J Surg (London England)"},{"key":"B171","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12943-025-02341-7","article-title":"The EGR1-mediated lncRNA TENM3-AS1 potentiates gastric cancer metastasis via reprogramming fatty acid metabolism","volume":"24","author":"Tang","year":"2025","journal-title":"Mol Cancer"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801318\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:34:21Z","timestamp":1783575261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1801318\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":171,"alternative-id":["10.3389\/fimmu.2026.1801318"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1801318","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1801318"}}